DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

SEGALL BRYANT & HAMILL, LLC's Holding History (CIK: 0001006378)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 537,000 Value ($000) $8,866 Avg Close $16.88 Range $13.75 - $20.61

Q3 2025

Shares 512,958 Value ($000) $7,448 Avg Close $14.37 Range $12.58 - $16.20

Q2 2025

Shares 500,559 Value ($000) $7,003 Avg Close $14.07 Range $10.57 - $16.97

Q1 2025

Shares 281,139 Value ($000) $3,822 Avg Close $19.16 Range $13.30 - $24.34

Q4 2024

Shares 289,075 Value ($000) $5,891 Avg Close $25.60 Range $19.93 - $33.33

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	537,000	$8,866	$16.88	$13.75 - $20.61
Q3 2025	512,958	$7,448	$14.37	$12.58 - $16.20
Q2 2025	500,559	$7,003	$14.07	$10.57 - $16.97
Q1 2025	281,139	$3,822	$19.16	$13.30 - $24.34
Q4 2024	289,075	$5,891	$25.60	$19.93 - $33.33